HA35 Acute Alcohol Study
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- The Cleveland Clinic
- Study ID
- NCT05025865
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Healthy Controls
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Sodium Hyaluronate — DRUGSodium Hyaluronate of molecular weight 35 kDa will be given in capsule form to the study participants.
- Placebo — DRUGA placebo will be given in capsule form to study participants.
Study Details
Eligible subjects will be asked to take a placebo/treatment capsule for a total of 3 days and then participate in a study visit on the fourth day. This study visit will include a medical exam, clinical labs, questionnaires, body composition measurements, and urine and stool collections. Additionally, participants will consume a sugar cocktail to measure their gut permeability, participate in an acute ethanol challenge, and undergo two muscle biopsies. The study will take approximately 3-4 hours and a designated driver will need to drive the participant home. On the fifth day, you will be asked to return to drop of the 24-hour urine collection.
Key Dates
- Start date
- Feb 1, 2022
- Status verified
- Nov 2025
- Primary completion
- Oct 1, 2026
- Completion
- Oct 1, 2027
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Placebo Comparator: HA35 Placebo Group12 study participants will be given a placebo capsule to take once per day in the morning with breakfast for 3 days.
- Active Comparator: HA35 Treatment Group12 study participants will be given an HA35 capsule to take once per day in the morning with breakfast for 3 days.
Primary Outcome Measure
Change in Aspartate Aminotransferase (AST) [ Time Frame: Baseline to day 4 ]
Central Contacts
- Srinivasan Dasarathy, MD216-318-7010
- Annette Bellar
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic | Cleveland | Ohio | 44195 | Annette Bellar |
Find similar trials in Cleveland, OH
Related Studies
- Measuring the Healthy Pediatric Inflammatory Response to Vaccination.Enrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET StudyRecruiting · Yale University · New Haven, Connecticut
- A Repository to Study Host-Microbiome Interactions in Health and DiseaseRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- PET Imaging Evaluation of [11C]SY08EARLY_PHASE1 · Recruiting · Massachusetts General Hospital · Charlestown, Massachusetts